These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3905320)

  • 21. Lidocaine extraction by the in vivo and isolated perfused pig liver.
    Mets B; Hickman R; Chalton D
    J Hepatol; 1994 Dec; 21(6):1067-74. PubMed ID: 7699229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man.
    Gottlieb ME; Stratton HH; Newell JC; Shah DM
    Arch Surg; 1984 Mar; 119(3):264-8. PubMed ID: 6696619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of SKF-525A and of altered hepatic blood flow on lidocaine clearance in the cat.
    Lautt WW; Skelton FS
    Can J Physiol Pharmacol; 1977 Feb; 55(1):7-12. PubMed ID: 843992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of increased plasma protein binding on the disposition of quinidine in turpentine-treated rats.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    Biol Pharm Bull; 1993 Jan; 16(1):63-7. PubMed ID: 8369755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):588-95. PubMed ID: 6149909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
    Vu VT; Chen CP
    Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic change in the liver following hepatic resection in the dog. A comparative study by the 198Au colloid method, KICG and the H2 clearance method].
    Tsumura M
    Nihon Geka Gakkai Zasshi; 1986 May; 87(5):536-46. PubMed ID: 3012315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lidocaine kinetics: relationships between early lidocaine kinetics and indocyanine green clearance.
    Zito RA; Reid PR
    J Clin Pharmacol; 1981; 21(2):100-5. PubMed ID: 7229115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic and renal clearances of lidocaine in conscious and anesthetized sheep.
    Mather LE; Runciman WB; Carapetis RJ; Ilsley AH; Upton RN
    Anesth Analg; 1986 Sep; 65(9):943-9. PubMed ID: 3740492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of drug disposition in patients with cirrhosis.
    Huet PM; Villeneuve JP
    Hepatology; 1983; 3(6):913-8. PubMed ID: 6629320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of pentobarbital, quinidine, lidocaine, and theophylline in the thermally injured rat.
    Fruncillo RJ; DiGregorio GJ
    J Pharm Sci; 1984 Aug; 73(8):1117-21. PubMed ID: 6491915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of serum concentration time course of quinidine in human using a physiologically based pharmacokinetic model developed from the rat.
    Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacobiodyn; 1986 Feb; 9(2):132-8. PubMed ID: 3712213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic transport of indocyanine green in dogs chronically intoxicated with dimethylnitrosamine.
    Kawasaki S; Umekita N; Beppu T; Wada T; Sugiyama Y; Iga T; Hanano M
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):309-17. PubMed ID: 6474462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha1-acid glycoprotein concentration and protein binding in trauma.
    Edwards DJ; Lalka D; Cerra F; Slaughter RL
    Clin Pharmacol Ther; 1982 Jan; 31(1):62-7. PubMed ID: 7053306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of propranolol, quinidine, procainamide and lidocaine in chronic renal disease.
    Lowenthal DT
    Am J Med; 1977 Apr; 62(4):532-8. PubMed ID: 851126
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.
    Daneshmend TK; Ene MD; Parker G; Roberts CJ
    Gut; 1984 Feb; 25(2):125-8. PubMed ID: 6693040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.
    Tucker GT; Bax ND; Lennard MS; Al-Asady S; Bharaj HS; Woods HF
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):21S-28S. PubMed ID: 6146336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.